RSVoice
A study evaluating the safety and immune response of an investigational vaccine aimed at preventing RSV infection in high risk adults.
A study evaluating the safety and immune response of an investigational vaccine aimed at preventing RSV infection in high risk adults.
A study to assess the impact on hospitalisations due to RSV infection (respiratory syncytial virus) in infants across the UK, France and Germany.
Discover how uMed facilitated biomarker collection from 335 patients in less than 3 months.
Find out how uMed helped successfully recruit 73% of referred patients into this study within 21 days, not only meeting but far exceeding the study’s recruitment objectives...
Discover how uMed supported this study with full end-to-end patient recruitment alongside device distribution, training, and data collection and aggregation.
Learn how uMed linked aggregated health record data to build a highly relevant and diverse cohort of study candidates.